ANI Pharmaceuticals, Inc. (ANIP)

65,36 +0,41 (+0,63%) Al cierre: 04:00PM EDT

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 642

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Nikhil Lalwani	President, CEO & Director	2,32M	373,22k	1978
Mr. Stephen P. Carey	Senior VP of Finance & CFO	1,11M	N/A	1971
Mr. Chad Gassert	Senior Vice President of Corporate Development & Strategy	849,71k	N/A	1976
Mr. Christopher K. Mutz	Senior Vp & Head of Rare Disease	867,92k	N/A	1972
Mr. Ori Gutwerg	Senior Vice President of Generics	895,16k	436,25k	1975
Mr. Muthusamy Shanmugam MS R.Ph.	Head of R&D, COO of Novitium Operations & Director	N/A	N/A	1968
Mr. James G. Marken	Senior Vice President of Operations & Product Development	673,23k	N/A	1963
Ms. Meredith W. Cook	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1975
Ms. Krista L. Davis	Senior VP & Chief Human Resources Officer	N/A	N/A	1974
Ms. Elizabeth Powell J.D.	Chief Compliance Officer & Head of Legal of Rare Disease	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Gobierno corporativo

El ISS Governance QualityScore de ANI Pharmaceuticals, Inc., a día 1 de abril de 2024, es 6. Las puntuaciones base son Auditoría: 10; Tablero: 5; Derechos de los accionistas: 6; Compensación: 4.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.